Comparative Pharmacology
Head-to-head clinical analysis: METHADONE HYDROCHLORIDE INTENSOL versus QDOLO.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADONE HYDROCHLORIDE INTENSOL versus QDOLO.
METHADONE HYDROCHLORIDE INTENSOL vs QDOLO
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist. It also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake. Its long duration of action is due to high protein binding and tissue sequestration.
Tramadol is a centrally acting synthetic opioid analgesic. It binds to μ-opioid receptors and inhibits norepinephrine and serotonin reuptake.
Oral: 2.5-10 mg every 8-12 hours; titrate slowly. Typical adult dose: 5-10 mg PO every 8-12 hours.
Oral: 50-100 mg every 4-6 hours as needed for pain; maximum 400 mg per day. Immediate-release tablets only. Extended-release formulations require different dosing and are not interchangeable.
None Documented
None Documented
Terminal elimination half-life ranges from 15 to 60 hours (mean ~24-36 hours). The long half-life allows for once-daily dosing in maintenance therapy but risk of accumulation and delayed toxicity during initiation.
Terminal elimination half-life approximately 2-4 hours in adults; prolonged to 4-6 hours in elderly and up to 12-16 hours in severe renal impairment (CrCl <30 mL/min)
Methadone is primarily eliminated via feces (about 50-60%) and urine (about 20-30%), with approximately 10% as unchanged drug in urine. Biliary excretion contributes to fecal elimination.
Renal 90% (60% unchanged, 30% as glucuronide conjugate), fecal 10%
Category D/X
Category C
Opioid Agonist
Opioid Agonist